Use of irradiated blood components: Practice parameter

American Journal of Clinical Pathology

Volumn 106, Issue 1, 1996, Pages 6-11

  Przepiorka, Donna ^a   Leparc, German F ^b   Stovall, Marilyn A ^a   Werch, Jochewed ^c   Lichtiger, Benjamin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Blood irradiation; Directed donations; Family donors; Platelet irradiation; Transfusion associated graft versus host disease

Indexed keywords

BLOOD TRANSFUSION; CELLULAR IMMUNITY; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HISTOCOMPATIBILITY; IRRADIATION; PRIORITY JOURNAL; REVIEW; SAFETY;

EID: 0029950804     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.1.6     Document Type: Review

References (55)

1. Brubaker DB. Human posttransfusion graft-versus-host disease. Vox Sang 1983;45:401-420.
2. Greenbaum BH. Transfusion-associated graft-versus-host disease: Historical perspective, incidence and current use of irradiated blood products. J Clin Oncol 1991;9:1889-1902.
3. Sacher RA, Luban NLC. Transfusion-associated graft-versus-host disease. In; Rossi EC, Simon TL, Moss GS, eds. Principles of Transfusion Medicine. Baltimore: Williams and Wilkins, 1991, pp 649-659.
4. Shimodo T. On postoperative erythroderma. Geka 1955;17:487-492.
5. Hathaway WE, Githens JH, Blackburn WR, Fulginiti V, Kempe CH. Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. N Engl J Med 1965;273:953-958.
6. Mathe G, Bernard J, de Vries MJ, et al. Nouveaux essais de greffe de moelle osseuse homolgue apres iiradiation totale chez des enfants atteints de leucemie aige en remission: Le probleme due syndrome secondaure chez l'homme. Rev Hematol 1960;15: 115-161.
7. Thomas ED, Herman EC, Greenough WB, et al. Irradiation and marrow infusion in leukemia. Arch Intern Med 1961;107:829-845.
8. Terasaki PJ. Identification of the type of blood cells responsible for the graft-versus-host reaction in chicks. J Exp Morphol 1959;7: 394-402.
9. Reisner Y, Kapoor N, Kirkpatrick D. et al. Transplantation for acute leukemia with HLA-A and B non-identical parenteral marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981;2:237-239.
10. Lee TH, Donegan E, Slichter S, Busch MP. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 1995;85:1207-1214.
11. Billingham RE. The biology of graft-versus-host reactions. Harvey Lecture 1966;62:21-78.
12. Kernan NA, Collins NH, Juliano L, et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-versus-host disease. Blood 1986;68:770-773.
13. Rubinstein A, Radl J, Cottier H, Rossi E, Guyler E. Unusual combined immunodeficiency syndrome exhibiting kappa-IgD paraproteinemia, residual gut immunity and graft-versus-host reaction after plasma infusion. Acta Paediatr Scand 1973;62:365-372.
14. Crowley JP, Skrabut EM, Valeri CR. Immunocompetent lymphocytes in previously frozen washed red cells. Vox Sang 1974;26: 513-517.
15. Otsuka S, Kunieda K, Hirose M, et al. Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy. Transfusion 1989;29:544-548.
16. Petz LD, Calhoun L, Yam P, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: Report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 1993;33:742-750.
17. Von Fliedner V, Higby DJ, Kim U. Graft-versus-host reaction following blood transfusion. Am J Med 1982;72:951-959.
18. Juji T, Takahashi K, Shibata Y, et al. Post-transfusion graft-verus-host disease in immunocompetent patients after cardiac surgery in Japan. N Engl J Med 1989;321:56.
19. Anderson KC, Goodnough LT, Sayers M, et al. Variation in blood component irradiation practice: Implications for prevention of transfusion-associated graft-versus-host disease. Blood 1991; 2096-2102.
20. Jamieson NV, Joysey V, Friend PJ, et al. Graft-versus-host disease in solid organ transplantation. Transplant International 1991;4: 67-71.
21. Spitzer TR, Cahill R, Cottler-Fox, M, et al. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. Cancer 1990;66:2346-2349.
22. Zulian GB, Roux E, Tiercy JM, et al. Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine):demonstration of exogenous DNA in various tissue extracts by PCR analysis. Br J Haematol 1995;89:83-89.
23. Smith KJ, Skelton HG, Yeager J, et al. Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. J Am Acad Dermatol 1993;28:167-173.
24. Takahashi K, Juji T, Miyamoto M, et al. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Lancet 1994;343:700-702.
25. Kanter MH. Transfusion-associated graft-versus-host disease: Do transfusion from second-degree relatives pose a greater risk than those from first-degree relatives? Transfusion 1992;32:323-327.
26. Benson K, Noll L, Andrade I, Benson J. Frequency of HLA-A,B heterozygous patients receiving HLA-A,B homozygous platelets: Risk of transfusion associated GVHD from HLA matched platelets. Blood 1993;82 (suppl):586a.
27. Benson K, Marks AR, Marshall MJ, Goldstein JD. Fatal graft-versus-host disease associated with transfusion of HLA-matched, HLA-homozygous platelets from unrelated donors. Transfusion 1994;34:432-437.
28. Hatley RM, Reynolds M, Paller AS, Chou P. Graft-versus-host disease following ECMO. J Pediatr Surg 1991;26:317-319.
29. Mettey R, Alcalay D, Deleplanque P, et al. Neonatal exchange transfusion with irradiated whole blood. Arch Pediatr 1989;46: 405-409.
30. Valerius NH, Johansen KS, Nielsen OS, et al. Effect of in vitro X-irradiation on lymphocyte and granulocyte function. Scand J Haematol 1981;27:9-18.
31. Rosen NR, Weidner JG, Boldt HD, Rosen DS. Prevention of transfusion-associated graft-versus-host disease: Selection of an adequate dose of gamma radiation. Transfusion 1993;33:125-127.
32. Pelszynski MM, Moroff G, Luban NL, Taylor BJ, Quinones RR. Effect of gamma irradiation by limiting dilution analysis: Implications for preventing transfusion-associated graft-versus-host disease. Blood 1994;83:1683-1689.
33. Drobyski W, Thibodeau S, Truitt RL, et al. Third party mediated graft rejection and graft-versus-host disease after T-cell depleted bone marrow transplantation as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood 1989;74: 2285-2294.
34. Leitman SF, Holland PV. Irradiation of blood products. Transfusion 1985;25:293-303.
35. Button LN, DeWolf WC, Newburger PE, Jacobson MS, Kevy SV. The effects of irradiation on blood components. Transfusion 1981;21:419-426.
36. Hillyer CD, Tiegerman KO, Berkman EM. Evaluation of the red cell storage lesion after irradiation in filtered packed red cell units. Transfusion 1991;31:497-499.
37. Davey RJ, McCoy NC, Yu M, et al. The effect of prestorage irradiation on posttransfusion red cell survival. Transfusion 1992;32: 525-528.
38. Ramirez AM, Woodfield DG, Scott R, McLachlin J. High potassium levels in stored irradiated blood. Transfusion 1987;27: 444-445.
39. Rivet C, Baxter A, Rock G. Potassium levels in irradiated blood. Transfusion 1989;29:185.
40. Buescher ES, Gallin JI. Radiation effects on cultured human monocytes and on monocyte-derived macrophages. Blood 1984;63:1402-1409.
41. Read EJ, Kodis C, Carter CS, Leitman SF. Viability of platelets following storage in the irradiated state. Transfusion 1988;28: 446-450.
42. Masterson ME, Febo R. Pretransfusion blood irradiation: Clinical rationale and dosimetric considerations. Med Phys 1992;19: 649-657.
43. Cameron JR, Suntharalingam N, Kenney GN. Thermoluminescent dosimetry. Madison: University of Wisconsin, 1968.
44. Reece MH, Thomson I: Semiconductor MOSFET dosimetry. Proceedings of Health Physics Society Annual Meeting, Boston, MA, July 4-8, 1988.
45. Lewis MC. Blood irradiation: Rationale and technique. Med Dosim 1990;15:119-120.
46. Dzik WH, Jones KS. The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte culture. Transfusion 1993;33:493-496.
47. Heim MU, Munker R, Sauer H, et al. Graft-versus-host disease with fatal outcome after administration of filtered erythrocyte concentrations. Beitr Infusionther 1992:30:178-181.
48. Akahoshi M, Takanashi M, Masuda M, et al. A case of transfusion-associated graft-versus-host disease not prevented by white cell reduction filters. Transfusion 1992;2:169-172.
49. Garcia-Gala JM, Ramirez-Payer A, Rayon C, et al. Chronic post-transfusion graft-versus-host disease in a patients with non-Hodgkin's lymphoma. Sangre 1993;38:489-491.
50. van Prooijen HC, Aarts-Riemens MI, Grijzenhout MA, van Weelden H. Ultraviolet irradiation modulates MHC-alloreactive cytotoxic T-cell precursors involved in the onset of graft-versus-host disease. Br J Haematol 1992;81:73-76.
51. Deeg HJ, Graham TC, Gerhard-Miller L, et al. Prevention of transfusion-induced graft-versus-host disease in dogs by ultraviolet irradiation. Blood 1989;74:2592-2595.
52. Oluwole SF, Engelstad K. Hardy MA. Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum. Transplant Proc 1992;24:2858-2859.
53. Pamphilon DH, Corbin SA, Saunders J, Tandy NP. Application of ultraviolet light in the preparation of platelet concentrates. Transfusion 1989;29:379-383.
54. Johnson RB, Napychank PA, Murphy S, Snyder EL. In vitro changes in platelet function and metabolism following increasing doses of ultraviolet B irradiation. Transfusion 1993;33:249-255.
55. Sherman L, Menitove J, Kagen LR, et al. Ultraviolet-B irradiation of platelets: A preliminary trial of efficacy. Transfusion 1992;32: 402-407.